Form 4: Boston Scientific Director Ellen M. Zane Receives Annual Equity Award

Director Ellen M. Zane acquired 2,901 shares of Boston Scientific common stock as an annual equity award.

Summary

• On May 9, 2024, Ellen M. Zane, a director of Boston Scientific Corp, acquired 2,901 shares of common stock.
• The acquisition was an annual equity award.
• The shares were acquired at a price of $0.0000.
• Following the transaction, Zane directly owns 48,530 shares of Boston Scientific common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine equity grant to a director, which is generally viewed positively as it aligns director interests with shareholders. There are no indications of negative news or concerns.

Positives

• The acquisition of shares by a director signals confidence in the company's future.

Industry Context

Equity awards to directors are a common practice in publicly traded companies to align their interests with those of shareholders.

Comparison to Industry Standards

• Director compensation packages, including equity awards, vary significantly across the medical device industry.
• Companies like Medtronic and Abbott also utilize equity grants as part of their director compensation.
• The size and vesting schedule of these grants are typically benchmarked against peer companies to ensure competitiveness.

Stakeholder Impact

• The equity award aligns the director's interests with those of shareholders, potentially encouraging decisions that benefit the company's long-term value.

Next Steps

• The restricted stock will vest upon the next annual meeting of stockholders.

Key Dates